Solan Headlines

Dynamic Comply Launches AI Governance Solutions for ISO 42001, NIST AI RMF, EU AI Act, and other Compliance Frameworks

Dynamic Comply Launches AI Governance Solutions for ISO 42001, NIST AI RMF, EU AI Act, and other Compliance Frameworks

Specialized consulting firm empowers organizations with comprehensive AI risk management and regulatory readiness services Leesburg, Virginia – July 10, 2025 – Dynamic Comply, a leading AI governance and compliance consulting firm,

Read Full Article

Founding Church of Scientology Celebrates 70th Anniversary in Washington, D.C.

Commemorating Seven Decades of Spiritual Service, Civic Engagement, and Historical Legacy. Washington, D.C. – During July, the Founding Church of Scientology is marking a major milestone: 70 years since its official

Read Full Article

Multiple System Atrophy Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Neuramedy Co.,Ltd, ProMIS Neurosciences, Enterin Inc., Nippon

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Multiple System Atrophy pipeline constitutes 20+ key companies continuously working towards developing 22+ Multiple System Atrophy treatment therapies, analysis of

Read Full Article

PI3K Inhibitor Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | OnKure Therapeutics, Eli Lilly, BeiGene, Relay Therapeutics, Rhizen Pharmaceuticals, Curis

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, PI3K Inhibitor pipeline constitutes 20+ key companies continuously working towards developing 25+ PI3K Inhibitor treatment therapies, analysis of Clinical Trials,

Read Full Article

Fanconi Anemia Pipeline 2025: MOA, ROA, and Clinical Trial Insights Explored by DelveInsight | Foresee Pharma, Rocket Pharma, John Diaz, Novartis, Sierra Oncology

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Fanconi Anemia pipeline constitutes 3+ key companies continuously working towards

Read Full Article

Aspergillosis Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis By DelveInsight | KBio, SCYNEXIS, Matinas BioPharma Holdings, Inc., Cipla/Pulmatrix, Pulmocide, F2G

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Aspergillosis pipeline constitutes 10+ key companies continuously working towards developing

Read Full Article

Mantle Cell Lymphoma Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | PharmaEngine, Jiangsu Hansoh Pharma, Galapagos NV, Miltenyi Biomedicine

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Mantle Cell Lymphoma pipeline constitutes 20+ key companies continuously working

Read Full Article

KRAS Inhibitors Drugs Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Target Population, Revenue, Statistics, MOA, ROA and Companies DelveInsight

KRAS Inhibitors Drugs Market KRAS Inhibitors companies working in the market are Novartis, Roche, Genentech, Verastem Oncology, Revolution Medicines, Cardiff

Read Full Article

MASH Market Forecast 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Statistics, Revenue, Patient Pool, MOA, ROA and Companies by DelveInsight

MASH Market MASH Companies are Hepion Pharmaceuticals, Ionis Pharmaceuticals, Galectin Therapeutics, Novo Nordisk A/S, Cirius Therapeutics, HighTide Biopharma, Boehringer Ingelheim,

Read Full Article

Synovial Sarcoma Pipeline Appears Robust With 15+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

DelveInsight’s, “Synovial Sarcoma Pipeline Insight, 2025” report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Synovial Sarcoma

Read Full Article